Barclays
STJ

Barclays’s St Jude Medical STJ Stock Holding History

Barclays’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-2,926,524
Closed -$235M – 7247
2016
Q4 		$235M Buy
2,926,524
+5,994
+0.2% +$476K 0.25% 53
2016
Q3 		$233M Sell
2,920,530
-932,683
-24% -$75.3M 0.26% 50
2016
Q2 		$301M Buy
3,853,213
+3,687,846
+2,230% +$263M 0.39% 30
2016
Q1 		$9.1M Buy
165,367
+30,992
+23% +$1.69M 0.01% 811
2015
Q4 		$8.2M Sell
134,375
-30,112
-18% -$1.9M 0.01% 1000
2015
Q3 		$10.4M Sell
164,487
-24,392
-13% -$1.74M 0.01% 911
2015
Q2 		$13.8M Sell
188,879
-12,219
-6% -$883K 0.02% 843
2015
Q1 		$13.1M Sell
201,098
-50,948
-20% -$3.39M 0.02% 924
2014
Q4 		$16.4M Sell
252,046
-42,864
-15% -$2.76M 0.02% 867
2014
Q3 		$17.7M Buy
294,910
+82,684
+39% +$5.4M 0.02% 793
2014
Q2 		$14.6M Sell
212,226
-94,890
-31% -$6.15M 0.02% 902
2014
Q1 		$20M Sell
307,116
-357,472
-54% -$23.3M 0.02% 689
2013
Q4 		$40.5M Buy
664,588
+329,857
+99% +$19.1M 0.04% 417
2013
Q3 		$17.7M Buy
334,731
+12,579
+4% +$648K 0.02% 736
2013
Q2 		$14.7M Buy
+322,152
New +$14M 0.02% 816

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Barclays's STJ Position: Q1 2017 in Review

Barclays sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 2,926,524 shares — an estimated $235M sold.

Barclays first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $301M in Q2 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Barclays reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Barclays sold 2,926,524 St Jude Medical shares in Q1 2017, an estimated $235M.
  • Barclays first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Barclays's St Jude Medical position peaked at $301M in Q2 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Barclays's 13F filing for Q1 2017, filed 15 May 2017.